Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden.

Gisela Kobelt, Johan Berglund, P Lindgren, B Jonsson, L Stawiarz, J Hillert

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Fingeravtryck

Fördjupa i forskningsämnen för ”Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden.”. Tillsammans bildar de ett unikt fingeravtryck.

Medicine and Dentistry

Nursing and Health Professions

Psychology

Neuroscience